Siimon Vaske
Fund Manager and Chief Executive Officer @ Trio Impact Invest
Siimon Vaske is a seed investor at Trio Impact Invest focused on Biotechnology and Biopharma.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Siimon Vaske invests in
Stages Siimon Vaske invests in
Countries Siimon Vaske invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (67%)
- Biopharma 1 (33%)
- CleanTech 1 (33%)
- Clean Energy 1 (33%)
- Pharmaceutical 1 (33%)
Stage
- Seed 1 (33%)
- Pre-Seed 1 (33%)
- Venture - Series Unknown 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Caplyzer develops and patented a new solution for water electrolysis. | $726.6K / Seed / Jul 07, 2026 | ||
| GenomeVault is a biodiversity startup that converts eDNA from nature into scalable biodiversity insights using advanced genomics. | $515.3K / Pre-Seed / Jul 07, 2026 | ||
| AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies. | Venture - Series Unknown / Feb 19, 2026 |
Co-Investors
About Trio Impact Invest
Trio Impact Invest is a venture capital investment firm.
Trio Impact Invest Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Siimon Vaske
Fund Manager and Chief Executive Officer
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Siimon Vaske invest in?
Siimon Vaske invests primarily in Biotechnology, Biopharma and CleanTech startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Siimon Vaske?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Siimon Vaske last invest?
The most recent investment recorded for Siimon Vaske closed in Jul 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
